Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-19 Sale |
2025-02-21 6:07 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
10,300 | $1.01 | $10,403 | 316,604 (Direct) |
View |
| 2025-02-19 Sale |
2025-02-21 6:06 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer |
11,040 | $1.01 | $11,150 | 324,292 (Direct) |
View |
| 2025-02-19 Sale |
2025-02-21 6:04 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
23,774 | $1.01 | $24,012 | 1,087,311 (Indirect Direct) |
View |
| 2024-12-23 Sale |
2024-12-26 7:04 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer |
49,962 | $0.89669 | $44,800 | 335,332 (Direct) |
View |
| 2024-12-19 Sale |
2024-12-20 8:33 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
51,115 | $0.94 | $48,048 | 326,904 (Direct) |
View |
| 2024-12-17 Sale |
2024-12-19 9:08 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
132,030 | $0.99712 | $131,650 | 1,111,085 (Indirect Direct) |
View |
| 2024-11-19 Sale |
2024-11-20 8:37 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
7,785 | $1.01 | $7,863 | 243,019 (Direct) |
View |
| 2024-11-19 Sale |
2024-11-20 8:36 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer |
6,407 | $1.01 | $6,471 | 218,856 (Direct) |
View |
| 2024-11-19 Sale |
2024-11-20 8:36 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
16,278 | $1.01 | $16,441 | 832,490 (Indirect Direct) |
View |
| 2024-08-19 Sale |
2024-08-20 9:15 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
6,866 | $1.28 | $8,788 | 250,804 (Direct) |
View |
| 2024-08-19 Sale |
2024-08-20 9:15 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer |
5,651 | $1.28 | $7,233 | 225,263 (Direct) |
View |
| 2024-08-19 Sale |
2024-08-20 9:14 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
14,881 | $1.28 | $19,048 | 848,768 (Indirect Direct) |
View |
| 2024-06-14 Sale |
2024-06-14 6:02 pm |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
19,500 | $1.2 | $23,400 | 261,573 (Indirect Direct) |
View |
| 2024-05-17 Sale |
2024-05-20 9:14 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
16,650 | $1.75 | $29,138 | 863,649 (Indirect Direct) |
View |
| 2024-05-17 Sale |
2024-05-20 9:13 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
7,355 | $1.75 | $12,871 | 257,670 (Direct) |
View |
| 2024-05-17 Sale |
2024-05-20 9:12 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer |
6,260 | $1.75 | $10,955 | 230,414 (Direct) |
View |
| 2024-05-10 Sale |
2024-05-13 4:36 pm |
NEKTAR THERAPEUTICS | NKTR | Deep Track Capital LP Deep Track Biotechnology Master Fund Ltd. KROIN DAVID 10% Owner |
56,000 | $1.7791 | $99,630 | 18,344,000 (Indirect) |
View |
| 2024-02-20 Sale |
2024-02-22 8:19 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
9,014 | $0.68 | $6,130 | 265,025 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-22 8:17 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer |
7,606 | $0.68 | $5,172 | 236,674 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-22 8:16 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
20,033 | $0.68 | $13,622 | 880,299 (Indirect Direct) |
View |
| 2023-11-17 Sale |
2023-11-20 9:02 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
9,646 | $0.49 | $4,727 | 274,039 (Direct) |
View |
| 2023-11-17 Sale |
2023-11-20 9:00 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer |
7,179 | $0.49 | $3,518 | 243,780 (Direct) |
View |
| 2023-11-17 Sale |
2023-11-20 8:58 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
19,877 | $0.49 | $9,740 | 900,332 (Indirect Direct) |
View |
| 2023-09-18 Sale |
2023-09-20 8:09 pm |
NEKTAR THERAPEUTICS | NKTR | Curet Myriam Director |
4,359 | $0.69 | $3,008 | 112,418 (Direct) |
View |
| 2022-09-22 Sale |
2023-09-20 8:08 pm |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
10,200 | $0.67 | $6,834 | 366,073 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-09-18 Ownership |
2025-01-17 8:39 pm |
N/A 2032-09-17 |
NEKTAR THERAPEUTICS | NKTR | WHITFIELD ROY A Director |
120,000 | $0 | 120,000 (Direct) |
View |
| 2024-09-18 Ownership |
2025-01-17 8:37 pm |
N/A 2032-09-17 |
NEKTAR THERAPEUTICS | NKTR | GREER R SCOTT Director |
120,000 | $0 | 120,000 (Direct) |
View |
| 2024-09-18 Ownership |
2025-01-17 8:35 pm |
N/A 2032-09-17 |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
120,000 | $0 | 120,000 (Direct) |
View |
| 2024-09-18 Ownership |
2025-01-17 8:32 pm |
N/A 2032-09-17 |
NEKTAR THERAPEUTICS | NKTR | Brainard Diana Director |
120,000 | $0 | 120,000 (Direct) |
View |
| 2024-09-18 Ownership |
2025-01-17 8:30 pm |
N/A 2032-09-17 |
NEKTAR THERAPEUTICS | NKTR | Ajer Jeffrey Robert Director |
120,000 | $0 | 120,000 (Direct) |
View |
| 2024-12-13 Option Award |
2024-12-17 8:55 pm |
N/A 2030-08-14 |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
780,000 | $0 | 1,023,019 (Direct) |
View |
| 2024-12-13 Option Award |
2024-12-17 8:54 pm |
N/A 2030-08-14 |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer |
822,813 | $0 | 1,042,169 (Direct) |
View |
| 2024-12-13 Option Award |
2024-12-17 8:54 pm |
N/A 2030-08-14 |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
2,531,875 | $0 | 3,364,365 (Direct) |
View |
Ownership |
2024-03-14 4:30 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | Deep Track Capital LP Deep Track Biotechnology Master Fund Ltd. KROIN DAVID 10% Owner |
0 | $0 | 18,400,000 (Indirect) |
View |
| 2023-12-13 Option Award |
2023-12-15 6:07 pm |
N/A 2031-12-12 |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2023-12-13 Option Award |
2023-12-15 6:05 pm |
N/A 2031-12-12 |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer |
325,000 | $0 | 325,000 (Direct) |
View |
| 2023-12-13 Option Award |
2023-12-15 6:05 pm |
N/A 2031-12-12 |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
1,300,000 | $0 | 1,300,000 (Direct) |
View |
| 2023-09-19 Option Award |
2023-09-21 8:07 pm |
N/A 2031-09-18 |
NEKTAR THERAPEUTICS | NKTR | GREER R SCOTT Director |
85,000 | $0 | 85,000 (Direct) |
View |
| 2023-09-19 Option Award |
2023-09-20 8:11 pm |
N/A 2031-09-18 |
NEKTAR THERAPEUTICS | NKTR | WHITFIELD ROY A Director |
85,000 | $0 | 85,000 (Direct) |
View |
| 2023-09-19 Option Award |
2023-09-20 8:09 pm |
N/A 2031-09-18 |
NEKTAR THERAPEUTICS | NKTR | Curet Myriam Director |
85,000 | $0 | 112,418 (Direct) |
View |
| 2023-09-19 Option Award |
2023-09-20 8:08 pm |
N/A 2031-09-18 |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
85,000 | $0 | 366,073 (Direct) |
View |
| 2023-09-19 Option Award |
2023-09-20 8:07 pm |
N/A 2031-09-18 |
NEKTAR THERAPEUTICS | NKTR | Brainard Diana Director |
85,000 | $0 | 85,000 (Direct) |
View |